The Brain's Own Cannabis System: Its Role in Memory and Drug Dependence | Research

The takeaway

A review found converging evidence that the endocannabinoid system modulates memory, with CB1 receptor blockade or knockout actually enhancing memory performance, and that this system also plays a role in opioid dependence.

Read this if you want to understand why cannabis affects memory and how the brain's own cannabinoid system works.

CB1 blockade or knockout consistently enhanced memory performance

What the researchers found

The review synthesized evidence from two approaches: pharmacological blockade of CB1 receptors using SR141716A, and genetic knockout mice lacking the CB1 receptor. Both approaches consistently showed enhanced performance across a variety of memory tasks, indicating that the endocannabinoid system normally acts to constrain or modulate cognitive function.

Cannabinoid intoxication produced cognitive deficits accompanied by changes in glutamatergic, GABAergic, and cholinergic systems in the hippocampus, each implicated in memory. The review also described evidence that the endocannabinoid system modulated opioid dependence, and that cannabis withdrawal produced a constellation of mild effects in dependent individuals.

Why it matters

The finding that blocking or removing the endocannabinoid system improved memory suggested that this system normally acts as a brake on memory formation. This had dual implications: it helped explain why cannabis impairs memory, and it suggested that CB1 antagonists might enhance cognition, a concept that was explored therapeutically.

The numbers in context

No specific quantitative data were presented in the abstract.

How the study worked

This was a narrative review synthesizing findings from pharmacological studies using the CB1 antagonist SR141716A, behavioral studies in CB1 receptor knockout mice, neurochemical studies of hippocampal systems, and research on cannabinoid-opioid interactions in dependence.

What this study cannot tell us

Much of the evidence came from animal studies using artificial interventions (complete receptor blockade or genetic knockout) that may not reflect the subtler modulation that occurs with normal endocannabinoid signaling. The review did not address potential negative consequences of blocking the endocannabinoid system.

How to read the evidence

This is a narrative review synthesizing converging evidence from pharmacological and genetic knockout studies, providing moderate-level evidence.

When this study was published

Published in 2002. The endocannabinoid system's role in memory has been extensively studied since, with the basic findings confirmed and expanded.

The bigger picture

The idea that CB1 antagonists could enhance cognition was explored pharmaceutically, though the CB1 antagonist rimonabant was eventually withdrawn from the market due to psychiatric side effects. The concept that the endocannabinoid system modulates memory remains central to neuroscience, and understanding these mechanisms has informed research on both cannabis effects and potential cognitive enhancers.

Questions still open

Could partial CB1 antagonism enhance memory without the psychiatric side effects seen with complete blockade? How does the endocannabinoid system's role in memory interact with its role in anxiety and emotional regulation?

Common questions

Why does cannabis impair memory?

Cannabis activates CB1 receptors that normally modulate memory formation. This review showed that when these receptors are blocked or removed, memory actually improves, suggesting the endocannabinoid system acts as a natural brake on memory processes that cannabis over-engages.

Could blocking the cannabis receptor improve memory?

Animal studies consistently showed this. However, a CB1 antagonist drug (rimonabant) was later withdrawn from the market because completely blocking this system caused depression and anxiety in humans, showing that the endocannabinoid system serves important functions beyond memory.

Read the original research

Endocannabinoids in cognition and dependence.

Prostaglandins, leukotrienes, and essential fatty acids, 66(2-3), 269-85

View on PubMed ↗

Citation

Lichtman, A H; Varvel, S A; Martin, B R. (2002). Endocannabinoids in cognition and dependence.. Prostaglandins, leukotrienes, and essential fatty acids, 66(2-3), 269-85.